<DOC>
	<DOCNO>NCT00122408</DOCNO>
	<brief_summary>The objective study assess effect daily enteral supplementation probiotic within population critically ill , mechanically ventilated patient . Especially , effect probiotic mortality rate intensive care medicine analyse .</brief_summary>
	<brief_title>Probiotic Enteral Administration Mechanically Ventilated Patients</brief_title>
	<detailed_description>In critically ill patient , gut integrity rapidly compromise either treatment use ( catecholamine antibiotic ) disease . This gut alteration favour adhesion and/or internalisation bacteria intestine cell lead production large amount cytokine rapidly reach blood compartment , induce neutrophil activation organ damage . Moreover , imbalance normal intestinal flora ( demonstrate early 24 hour ICU admission ) one mechanism involve development ventilator associate pneumonia ( VAP ) . VAP lead cause ICU-acquired infection responsible prolonged ICU stay , increased mortality cost . Probiotics , especially Lactobacillus Rhamnosus GG ( 'LGG ' ) , demonstrate possess beneficial effect term intestine flora imbalance immune response . Objective : To study effect probiotic mixture ( contain LGG ) enteral administration survival incidence VAP mechanically ventilate patient . Patients Methods : Prospective , randomize , double-blind , placebo-controlled study . After randomization , 740 intubated patient predictive length mechanical support 48 hour enterally receive either 10.10 cfu probiotic ( Ergyphilus , Nutergia , France ) identical placebo daily withdrawal mechanical support . The main endpoint mortality rate ICU . Secondary endpoint include hospital length stay mortality rate , VAP incidence number day free antibiotic . Length study 24 month . Perspectives : The objective demonstrate survival advantage due LGG administration , along reduction VAP episodes antibiotic use .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<criteria>Patients mechanical ventilation least 48 hour Age 18 Pregnancy Immunocompromised status Short bowel disease Moribund condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>ventilator-associated pneumonia</keyword>
	<keyword>probiotic</keyword>
	<keyword>mechanical ventilation</keyword>
	<keyword>intensive care</keyword>
</DOC>